Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LEE S SIMON

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1457494932
CMS profile
247966
Location
BOSTON, MA

General Payments · PY2018–2023

$803,758.35

  • Reported across 205 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$51,278.39

30 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $49,873.90 23
Honoraria $750.00 1
Travel and Lodging $348.19 1
Food and Beverage $306.30 5

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
Horizon Pharma plc $23,246.40 10
Aurinia Pharma U.S., Inc. $6,750.00 4
PFIZER INC. $6,125.00 2
Teikoku Pharma USA, Inc. $4,927.50 1
ABBVIE INC. $4,500.00 3
E.R. Squibb & Sons, L.L.C. $4,154.49 7
GlaxoSmithKline, LLC. $825.00 2
Pacira Pharmaceuticals Incorporated $750.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $236,593.18 50
PY2019 $236,599.57 57
PY2020 $86,365.00 18
PY2021 $100,916.95 23
PY2022 $92,005.26 27
PY2023 $51,278.39 30

Payment records · PY2023 (30)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20182019202020212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AbbVie Inc. $2,000.00 06/20/2023 Consulting Fee Undisputed 01/23/2026 999016681 CMS
AbbVie Inc. $500.00 09/08/2023 Consulting Fee Undisputed 01/23/2026 999016685 CMS
AbbVie Inc. $2,000.00 12/01/2023 Consulting Fee Undisputed 01/23/2026 999016689 CMS
Aurinia Pharma U.S., Inc. $625.00 02/13/2023 Consulting Fee Undisputed 01/23/2026 1057752303 CMS
Aurinia Pharma U.S., Inc. $1,000.00 03/03/2023 Consulting Fee Undisputed 01/23/2026 1057752305 CMS
Aurinia Pharma U.S., Inc. $4,625.00 05/04/2023 Consulting Fee Undisputed 01/23/2026 1057752307 CMS
Aurinia Pharma U.S., Inc. $500.00 11/06/2023 Consulting Fee Undisputed 01/23/2026 1057752309 CMS
E.R. Squibb & Sons, L.L.C. $60.00 10/20/2023 Food and Beverage Undisputed 01/23/2026 1016031735 CMS
E.R. Squibb & Sons, L.L.C. $30.00 10/20/2023 Food and Beverage Undisputed 01/23/2026 1016031739 CMS
E.R. Squibb & Sons, L.L.C. $134.67 10/20/2023 Food and Beverage Undisputed 01/23/2026 1016031883 CMS
E.R. Squibb & Sons, L.L.C. $51.63 10/20/2023 Food and Beverage Undisputed 01/23/2026 1016031887 CMS
E.R. Squibb & Sons, L.L.C. $30.00 10/20/2023 Food and Beverage Undisputed 01/23/2026 1016031891 CMS
E.R. Squibb & Sons, L.L.C. $348.19 10/20/2023 Travel and Lodging Undisputed 01/23/2026 1016031895 CMS
E.R. Squibb & Sons, L.L.C. $3,500.00 12/18/2023 Consulting Fee Undisputed 01/23/2026 1016031709 CMS
GlaxoSmithKline, LLC. $550.00 01/20/2023 Consulting Fee Undisputed 01/23/2026 1001607995 CMS
GlaxoSmithKline, LLC. $275.00 03/27/2023 Consulting Fee Undisputed 01/23/2026 1001608005 CMS
Horizon Therapeutics plc $4,350.00 01/17/2023 Consulting Fee Undisputed 01/23/2026 987076063 CMS
Horizon Therapeutics plc $725.00 02/10/2023 Consulting Fee Undisputed 01/23/2026 987076065 CMS
Horizon Therapeutics plc $1,160.00 03/16/2023 Consulting Fee Undisputed 01/23/2026 987076067 CMS
Horizon Therapeutics plc $5,365.00 04/26/2023 Consulting Fee Undisputed 01/23/2026 987076069 CMS
Horizon Therapeutics plc $1,885.00 05/09/2023 Consulting Fee Undisputed 01/23/2026 987076071 CMS
Horizon Therapeutics plc $1,305.00 06/13/2023 Consulting Fee Undisputed 01/23/2026 987076073 CMS
Horizon Therapeutics plc $3,190.00 08/09/2023 Consulting Fee Undisputed 01/23/2026 987076075 CMS
Horizon Therapeutics plc $1,786.40 09/13/2023 Consulting Fee Undisputed 01/23/2026 987076077 CMS
Horizon Therapeutics plc $1,885.00 09/15/2023 Consulting Fee Undisputed 01/23/2026 987076079 CMS
Horizon Therapeutics plc $1,595.00 11/02/2023 Consulting Fee Undisputed 01/23/2026 987076081 CMS
Pacira Pharmaceuticals Incorporated $750.00 05/01/2023 Honoraria Undisputed 01/23/2026 1041513021 CMS
PFIZER INC. $3,750.00 01/30/2023 Consulting Fee Undisputed 01/23/2026 1049118514 CMS
PFIZER INC. $2,375.00 08/07/2023 Consulting Fee Undisputed 01/23/2026 1049360849 CMS
Teikoku Pharma USA, Inc. $4,927.50 09/15/2023 Consulting Fee Undisputed 01/23/2026 1029790819 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.